News & Trends - Pharmaceuticals
Advancing the STEM gap with NYSF CEO and Organon Medical Director: National Science Week
![](https://www.healthindustryhub.com.au/wp-content/uploads/2023/08/Dr-Melanie-Bagg-CEO-National-Youth-Science-Forum-NYSF-Julie-Mullan-Medical-Director-ANZ-Organon-v2.png)
Joining Health Industry Hub for National Science Week are Dr Melanie Bagg, CEO of the National Youth Science Forum (NYSF), and Julie Mullan, Medical Director ANZ at Organon.
In this insightful discussion, we delve into critical matters surrounding the representation of women in STEM careers and the imperative steps needed to bridge the gender gap within the field. Dr Bagg, the first female CEO to lead NYSF in 40 years, and Ms Mullan bring their expertise and perspectives to shed light on the challenges and opportunities that lie ahead.
We explore a range of pressing questions, from the contributing factors behind the persistent gender disparity in STEM professions, to the recent systemic review by the Federal Government’s Women for STEM Ambassador. Our guests share their thoughts on how the key findings of this review can pave the way for tangible change and increased representation of women in STEM.
Furthermore, we dive into the alarming gender pay gap that plagues STEM fields, with women still earning significantly less than their male counterparts. Dr Bagg and Ms Mullan provide insights into the measures that can be undertaken to address this disparity and create a more equitable compensation landscape.
A central focal point of the discussion lies in exploring how companies such as Organon are actively driving gender equity progress within the STEM industry and serving as catalysts for pivotal transformative shifts. Moreover, our guests elaborate on strategies to enhance engagement with policymakers and wider communities, advocating for pivotal changes that empower women in STEM fields.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
![Medicines Australia and AusBiotech CEOs set agenda for the new year](https://www.healthindustryhub.com.au/wp-content/uploads/2025/01/Medicines-Australia-and-AusBiotech-CEOs-set-agenda-for-the-new-year.jpg)
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
![MTAA and PTA CEOs voice outlook for the year ahead](https://www.healthindustryhub.com.au/wp-content/uploads/2025/01/MTAA-and-PTA-CEOs-voice-outlook-for-the-year-ahead.jpg)
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreNews & Trends - Pharmaceuticals
![Scathing report exposes Labor’s mismanagement of the PBS](https://www.healthindustryhub.com.au/wp-content/uploads/2025/01/Scathing-report-exposes-Labors-mismanagement-of-the-PBS.jpg)
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More